Oct 28, 2025 02:00AM
Oct 23, 2025 04:00PM
Sep 4, 2025 04:01AM
Aug 30, 2025 10:00PM
Aug 11, 2022 07:27AM
Mar 31, 2022 01:00AM
May 29, 2020 04:01PM Sanofi announces closing of Regeneron stock sale
May 27, 2020 05:55AM
May 27, 2020 01:56AM
May 26, 2020 07:55PM
Oct 9, 2019 04:13AM
Sep 11, 2019 09:16AM
Sep 10, 2019 05:53PM
Aug 1, 2019 02:09AM Barclays Reiterates Equalweight Rating on Sanofi (SNY)
Jul 29, 2019 09:28AM
Jul 15, 2019 03:05AM
May 3, 2019 09:09AM
May 1, 2019 03:00AM
Apr 29, 2019 09:25AM
Nov 1, 2018 04:11AM
Oct 15, 2018 04:30AM Sanofi (SAN:FP) (SNY) PT Raised to EUR68 at Barclays
Jun 13, 2018 01:01AM
Jun 13, 2018 01:01AM
Jun 13, 2018 01:00AM
Jan 23, 2018 06:55AM
Nov 15, 2017 02:03AM
Mar 7, 2017 12:57PM
Mar 7, 2017 12:41PM Barclays Starts Sanofi-Aventis (SNY) at Underweight
Jul 6, 2016 09:30AM
May 12, 2016 10:38AM
May 12, 2016 08:01AM
May 3, 2016 10:24AM
Mar 29, 2016 12:00PM
Dec 15, 2015 10:02AM
Dec 10, 2015 10:55AM Notable Analyst Rating Changes 12/10: (CYBR) (JCP) (PAA) Upgraded; (SNY) (AMAT) (VRA) Downgraded
Oct 15, 2015 10:21AM
Jul 27, 2015 09:58AM
May 8, 2015 07:30AM
Jan 21, 2015 04:01PM
Oct 29, 2014 08:35AM
Apr 8, 2014 11:00AM
Mar 4, 2014 08:00AM BioMarin to Present at the Barclays Global Healthcare Conference in Miami
Sep 16, 2013 07:46AM
Jan 29, 2013 09:10AM
Jun 22, 2012 03:34PM
Jun 12, 2012 05:44PM
Jun 11, 2012 05:17PM
May 12, 2011 02:19PM
Apr 13, 2011 01:03PM Barclays Reiterates an 'Overweight' on Regeneron Pharma (REGN); Sticking with VTE Ahead of CATT Data
Mar 23, 2011 12:45PM

128,400 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All